Physician profile
Bryan Daniel Katz
NPI 1942696380
$1,515.51
in general payments reported to CMS, 2019-2025
7 companies · $399 in 2025
The $399 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $75.81 · 2021: $80.40 · 2022: $172 · 2023: $404 · 2024: $384 · 2025: $399.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,187.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,187.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,108.34 | 2021-2025 | Prostep Mica, Citrefix, Prostep |
| Horizon Therapeutics Plc | $125.00 | 2023 | Krystexxa |
| Smith+Nephew, INC. | $90.02 | 2019-2021 | |
| Treace Medical Concepts, INC. | $73.81 | 2022-2023 | |
| Paratek Pharmaceuticals, INC. | $52.31 | 2023-2025 | Nuzyra |
| Linvatec Corporation | $51.46 | 2025 | 5ms, In2bones USA, Biobrace 23mm |
| Kci USA, INC. | $14.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Katz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.